Bg pattern

PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

PULMOTEC Graphite Crucible for the Preparation of Technegas for Inhalation Radiochemical Reagent Preparation Equipment

High-purity graphite

Read this package leaflet carefully before this medicine is administered to you, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your nuclear medicine doctor, who will supervise the procedure.
  • If you experience side effects, consult your nuclear medicine doctor, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet:

  1. What PULMOTEC is and what it is used for
  2. What you need to know before starting to use PULMOTEC
  3. How to use PULMOTEC
  4. Possible side effects
  5. Storage of PULMOTEC
  6. Package Contents and Additional Information

1. What PULMOTEC is and what it is used for

This medicine is for diagnostic use only.

PULMOTEC, when in the presence of pertechnetate (Tc-99m) sodium and heated to 2550°C in a high-purity argon atmosphere, produces a carbon microparticle aerosol labeled with technetium (Tc-99m), called Technegas.

After inhaling Technegas, lung images can be recorded.

These images will help your doctor or nuclear medicine specialist observe if your lungs are abnormally ventilated. The use of Technegas is usually combined with the injection of another radiopharmaceutical agent into your veins to detect any anomalies in pulmonary blood flow.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use PULMOTEC

Warnings and Precautions:

  • Technegas is administered by specially trained personnel. Laws governing the use, possession, and handling of radioactive substances stipulate that this medicine can only be used in hospitals or similar institutions.

Your doctor or the nuclear medicine specialist performing the procedure will tell you if you need to take special precautions after using this medicine.

If you have any questions, consult your doctor or the nuclear medicine specialist performing the procedure.

  • The use of Technegas involves the administration of a small amount of radioactivity.

The risk associated with its use is very small. Your doctor or nuclear medicine specialist will prescribe this procedure only if they consider the risk to be significantly lower than the potential benefits.

Other Medicines and PULMOTEC:

To date, no interactions with other medicines are known.

Tell your nuclear medicine doctor if you are using or have recently used other medicines, including those purchased without a prescription.

Pregnancy and Breastfeeding:

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your nuclear medicine doctor before using this medicine.

It is essential that you inform your doctor or nuclear medicine specialist if you are pregnant or breastfeeding.

If you are pregnant:

The use of radiopharmaceuticals during pregnancy requires very special care.

Your doctor or nuclear medicine specialist will prescribe this procedure only if they consider the benefits to outweigh the potential risk.

If you are breastfeeding:

If the use of Technegas is considered essential while you are breastfeeding, your doctor or nuclear medicine specialist will ask you not to feed your child for 12 hours after use and to discard the milk produced during this time.

Driving and Using Machines

No studies have been conducted on the effect of this medicinal product on the ability to drive or use machines.

3. How to Use PULMOTEC

Your doctor or nuclear medicine specialist will know how much Technegas you need to use to achieve an image that provides the necessary medical information. For adults, the usual inhaled dose is around 40 MBq.

The becquerel (Bq) is a unit of radioactivity. MBq means megabecquerel.

Lower doses are used for children.

  • Technegas is inhaled. Since the first inhalation does not contain oxygen, you will be given oxygen for a few moments before inhaling Technegas. There are several possible ways to use this product: to determine which is the best way for you, you will be asked to try breathing through the mouthpiece without Technegas and then repeat it with the mouthpiece connected to the Technegas generator.
  • If you feel uncomfortable using the medicinal product, you can remove the mouthpiece from your mouth between two Technegas inhalations.
  • To achieve a homogeneous distribution of the medicinal product in your lungs, you may need to use Technegas while lying down.
  • A series of 4 to 6 images is usually sufficient for your doctor or nuclear medicine specialist to obtain the necessary information.

If you use more PULMOTEC than you should:

  • An overdose is virtually impossible. Doses are carefully prepared and verified.
  • If an overdose is suspected, your doctor or nuclear medicine specialist will ask you to drink plenty of fluids and urinate frequently.

If you have any other questions about using this medicine, ask your doctor or the nuclear medicine specialist performing the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

The frequencies of side effects are defined as follows:

Very common

Affects more than 1 in 10 users

Common

Affects 1-10 in 100 users

Uncommon

Affects 1-10 in 1,000 users

Rare

Affects 1-10 in 10,000 users

Very rare

Affects less than 1 user in 10,000

Not known

Frequency cannot be estimated from the available data

  • Rare cases of dizziness, drowsiness, and nausea have been reported. They are believed to be related to a temporary decrease in oxygen in the blood, produced in the first inhalation of Technegas, which does not contain oxygen. This risk is minimized by administering oxygen before inhaling Technegas.
  • If you experience these effects, the doctor or nuclear medicine specialist will let you breathe normal air or administer oxygen.

Reporting Side Effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of PULMOTEC

You will not need to obtain or store this medicine for diagnostic use. The center where the test is performed will do so.

The medicine label states the suitable storage conditions and expiration date. Hospital personnel will verify that the medicine is stored under the established conditions and not used after its expiration date.

6. Package Contents and Additional Information

PULMOTEC Composition:

  • The active substance is high-purity graphite (99.9%): 1.340 g in each crucible
  • There are no other excipients.

Appearance of the Product and Package Contents:

Radiochemical reagent preparation equipment.

Technegas is obtained by heating the radiopharmaceutical agent pertechnetate (99mTc) sodium to 2550°C in a high-purity graphite crucible. Technegas is a carbon microparticle aerosol suspended in argon gas.

PULMOTEC crucibles of 135 µL

Five shrink-wrapped (PVC-cardboard) packages with 10 crucibles of 135 µL per package of PULMOTEC in a cardboard box.

PULMOTEC crucibles of 300 µL

Five shrink-wrapped (PVC-cardboard) packages with 10 crucibles of 300 µL per package of PULMOTEC in a cardboard box.

Marketing Authorization Holder and Manufacturer:

Marketing Authorization Holder

CYCLOMEDICA IRELAND LTD

Unit A5 Calmount Business Park

Ballymount

Dublin 12

IRELAND

Manufacturer

Pharmapac Limited

Unit D1

Willow Drive

Naas Enterprise Park

Newhall

Naas

Co. Kildare

W91 E797

Ireland

Date of Last Revision of this Package Leaflet12/2024

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/

This information is intended only for healthcare professionals:

Please consult the summary of product characteristics.

Online doctors for PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION

Discuss questions about PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION?
PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION?
The active ingredient in PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION is technetium (99mTc) technegas. This information helps identify medicines with the same composition but different brand names.
Who manufactures PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION?
PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION is manufactured by Cyclomedica Ireland Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to PULMOTEC TM GRAPHITE CRUCIBLE FOR THE PREPARATION OF TECHNEGAS FOR INHALATION?
Other medicines with the same active substance (technetium (99mTc) technegas) include MACROAGGREGATES OF HUMAN ALBUMIN CURIUM 2 MG KIT FOR RADIOPHARMACEUTICAL PREPARATION, HUMAN ALBUMIN MACROAGGREGATES MEDI-RADIOPHARMA 2.5 mg KIT FOR RADIOPHARMACEUTICAL PREPARATION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media